These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy. Cortés-González JR; Castellanos E; Sandberg K; Eriksson MH; Wiklund P; Carlsson S; Cohn-Cedermark G; Harmenberg U; Gustafsson O; Levitt SH; Lennernäs B; Brandberg Y; Márquez M; Kälkner KM; Nilsson S Int J Oncol; 2013 Jan; 42(1):109-17. PubMed ID: 23151842 [TBL] [Abstract][Full Text] [Related]
24. CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer. Cai G; Zhu J; Palmer JD; Xu Y; Hu W; Gu W; Cai S; Zhang Z Radiat Oncol; 2015 Feb; 10():57. PubMed ID: 25889149 [TBL] [Abstract][Full Text] [Related]
25. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography. Mortensen MB Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296 [TBL] [Abstract][Full Text] [Related]
26. Neo-adjuvant chemoradiotherapy and multivisceral resection to optimize R0 resection of locally recurrent adherent colon cancer. Hallet J; Zih FS; Lemke M; Milot L; Smith AJ; Wong CS Eur J Surg Oncol; 2014 Jun; 40(6):706-12. PubMed ID: 24534363 [TBL] [Abstract][Full Text] [Related]
27. High subcortical sacrectomy: a novel approach to facilitate complete resection of locally advanced and recurrent rectal cancer with high (S1-S2) sacral extension. Shaikh I; Holloway I; Aston W; Littler S; Burling D; Antoniou A; Jenkins JT; Colorectal Dis; 2016 Apr; 18(4):386-92. PubMed ID: 26638828 [TBL] [Abstract][Full Text] [Related]
28. Single-stage anterior high sacrectomy for locally recurrent rectal cancer. Fawaz K; Smith MJ; Moises C; Smith AJ; Yee AJ Spine (Phila Pa 1976); 2014 Mar; 39(5):443-52. PubMed ID: 24573075 [TBL] [Abstract][Full Text] [Related]
29. Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision. Lee JH; Jang HS; Kim JG; Cho HM; Shim BY; Oh ST; Yoon SC; Kim YS; Choi BO; Kim SH Ann Surg Oncol; 2012 Apr; 19(4):1213-21. PubMed ID: 21935746 [TBL] [Abstract][Full Text] [Related]
30. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer. Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025 [TBL] [Abstract][Full Text] [Related]
31. The magnetic resonance imaging-based approach for identification of high-risk patients with upper rectal cancer. Chang JS; Lee Y; Lim JS; Kim NK; Baik SH; Min BS; Huh H; Koom WS Ann Surg; 2014 Aug; 260(2):293-8. PubMed ID: 24451474 [TBL] [Abstract][Full Text] [Related]
33. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244 [TBL] [Abstract][Full Text] [Related]
34. [Influence of a total focal dose of preoperative chemoradiotherapy on direct results of treatment of rectal cancer]. Rasulov AO; Shelygin IuA; Boĭko AV; Droshneva IV Vestn Khir Im I I Grek; 2011; 170(4):34-7. PubMed ID: 22191254 [TBL] [Abstract][Full Text] [Related]
35. Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results. Lococo F; Cesario A; Margaritora S; Dall'Armi V; Nachira D; Cusumano G; Meacci E; Granone P Ann Thorac Surg; 2012 May; 93(5):1633-40. PubMed ID: 22480394 [TBL] [Abstract][Full Text] [Related]
36. [Effect of postoperative complications on late recurrence and distant metastasis in patients previously treated with elective, curative resection of colorectal carcinoma]. Zsoldos P; Hegedüs L; Issekutz A; Oláh A Magy Seb; 2011 Apr; 64(2):74-81. PubMed ID: 21504856 [TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study. Hongo K; Kazama S; Tsuno NH; Ishihara S; Sunami E; Kitayama J; Watanabe T World J Surg Oncol; 2015 Jan; 13():7. PubMed ID: 25622595 [TBL] [Abstract][Full Text] [Related]
38. Treatment of Locally Recurrent Rectal Carcinoma in Previously (Chemo)Irradiated Patients: A Review. van der Meij W; Rombouts AJ; Rütten H; Bremers AJ; de Wilt JH Dis Colon Rectum; 2016 Feb; 59(2):148-56. PubMed ID: 26734974 [TBL] [Abstract][Full Text] [Related]
39. The depth of post-treatment perirectal tissue invasion is a predictor of outcome in patients with clinical T3N1M0 rectal cancer treated with neoadjuvant chemoradiation followed by surgical resection. Brandt WS; Yong S; Abood G; Micetich K; Walther A; Shoup M Am J Surg; 2014 Mar; 207(3):357-60; discussion 360. PubMed ID: 24456833 [TBL] [Abstract][Full Text] [Related]
40. [Palliative intraoperative irradiation of recurrent neck lymph node metastases in the head and neck area]. Spaeth J; Andreopoulos D; Unger T Laryngorhinootologie; 1997 Jan; 76(1):36-41. PubMed ID: 9156507 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]